Investor Frenzy Drives BIO Token to Record High Amid DeSci Revolution

Bio Protocol, a decentralized science initiative, has announced the launch of Aubrai, the first-ever decentralized AI agent focused on longevity science. Developed in collaboration with VitaDAO, Aubrai is designed to advance research in anti-aging and life extension, leveraging the power of decentralized science (DeSci). The AI agent is part of a broader strategy to transform scientific research into a more open, collaborative, and accessible ecosystem [2].

The launch of Aubrai has triggered a surge in the value of Bio Protocol's native token, BIO. Over the past 30 days, the price of BIO has risen by 301% from its all-time low, reaching a record high of $0.1745 [2]. This sharp increase has been attributed to growing investor interest in DeSci, with a particular focus on the token’s role in supporting innovative research projects such as Aubrai.

The token’s rise is also being driven by increasing whale accumulation, with major holders currently holding 21.6 million BIO tokens—over 1,180% more than in the previous 30 days [2]. Additionally, public figures have acquired over 7.79 million tokens, a 342,146% increase in the same period. This accumulation indicates strong confidence in the project’s future, particularly in the context of a broader shift toward decentralized scientific research and development.

From a supply perspective, the number of BIO tokens on exchanges has dropped by 8.7% to 417.6 million in the last 30 days, suggesting that investors are moving tokens into self-custody wallets. This trend is typical during accumulation phases and reinforces the perception of a bullish market for the token [2]. However, technical indicators suggest the possibility of a near-term correction. The RSI has reached 75, indicating overbought conditions, while the MFI and Stochastic indicators have also hit extreme levels. A pullback could follow if the price breaks below the key support level at $0.1023 [2].

Bio Protocol continues to expand its DeSci initiatives beyond Aubrai. Projects such as FatDAO, which addresses the obesity crisis, DogYears, which focuses on animal longevity, and Dalya, which is centered on drug development, are all part of the broader vision to decentralize scientific research and make it more transparent and participatory [2].

Source:

[1] Bio-protocol Journal | Bio-protocol (https://bio-protocol.org/en)

[2] Bio Protocol Price Prediction: Is a Big Reversal Coming? (https://www.banklesstimes.com/articles/2025/08/21/bio-protocol-price-prediction-is-big-reversal-coming/)